Business Wire

NanoString Launches New nCounter Pro Analysis System

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of ...
Business Wire

NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...
Business Insider

NanoString Highlights a Record Number of nCounter-Based Research Abstracts in Precision Oncology and Predictive Biomarkers at the 2017 American Association of Cancer Research ...

SEATTLE, March 27, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced ...
ascopubs.org

Colorectal cancer gene expression profiling using nanostring nCounter analysis.

Regular statin users and colorectal cancer (CRC) prognosis. Neoadjuvant chemoradiotherapy (NCRT) using concurrent S-1 and irinotecan in rectal cancer: Impact on long-term clinical outcomes and ...
ascopubs.org

Gene expression profiling of anaplastic thyroid carcinoma and coexisting differentiated thyroid carcinoma using the NanoString nCounter system.

A comparison of the burden of thyroid cancer amongst European Union 15+ countries, 1990-2017: Estimates from the Global Burden of Disease Study. This is an ASCO Meeting Abstract from the 2021 ASCO ...
Nasdaq

NanoString Launches nCounter TCR Diversity Panel and Analysis Package at the 2021 Annual Meeting of the Society for Immunotherapy of Cancer

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...